350 related articles for article (PubMed ID: 15610858)
1. Chromosomal aberrations in Cis and Ta bilharzial bladder cancer: a theory of pathogenesis.
Khaled HM; Aly MS; Mokhtar N
Urol Oncol; 2004; 22(6):443-7. PubMed ID: 15610858
[TBL] [Abstract][Full Text] [Related]
2. Can bladder adenocarcinomas be distinguished from schistosomiasis-associated bladder cancers by using array comparative genomic hybridization analysis?
Vauhkonen H; Böhling T; Eissa S; Shoman S; Knuutila S
Cancer Genet Cytogenet; 2007 Sep; 177(2):153-7. PubMed ID: 17854674
[TBL] [Abstract][Full Text] [Related]
3. Nonrandom chromosomal changes in transitional cell carcinoma of the bladder.
Gibas Z; Prout GR; Connolly JG; Pontes JE; Sandberg AA
Cancer Res; 1984 Mar; 44(3):1257-64. PubMed ID: 6692407
[TBL] [Abstract][Full Text] [Related]
4. Chromosomal aberrations in early-stage bilharzial bladder cancer.
Aly MS; Khaled HM
Cancer Genet Cytogenet; 2002 Jan; 132(1):41-5. PubMed ID: 11801307
[TBL] [Abstract][Full Text] [Related]
5. Detection of C-erb B2 gene amplification in bilharzial associated bladder cancer using fluorescence in situ hybridization.
Aly MS; Khaled HM
Urol Oncol; 2004; 22(6):448-52. PubMed ID: 15610859
[TBL] [Abstract][Full Text] [Related]
6. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.
Simonetti S; Russo R; Ciancia G; Altieri V; De Rosa G; Insabato L
Int J Surg Pathol; 2009 Jun; 17(3):198-205. PubMed ID: 19443884
[TBL] [Abstract][Full Text] [Related]
7. [Molecular cytogenetic study of bladder transitional cell carcinoma by FISH].
Shou J; Wang M; Ma J
Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):36-8. PubMed ID: 11776593
[TBL] [Abstract][Full Text] [Related]
8. Chromosomal high-polysomies predict tumour progression in T1 transitional cell carcinoma of the bladder.
Ribal MJ; Alcaraz A; Mengual L; Carrio A; Lopez-Guillermo A; Mallofré C; Palou J; Gelabert A; Villavicencio H
Eur Urol; 2004 May; 45(5):593-9. PubMed ID: 15082201
[TBL] [Abstract][Full Text] [Related]
9. Comparison of genetic changes in schistosome-related transitional and squamous bladder cancers using comparative genomic hybridization.
Muscheck M; Abol-Enein H; Chew K; Moore D; Bhargava V; Ghoneim MA; Carroll PR; Waldman FM
Carcinogenesis; 2000 Sep; 21(9):1721-6. PubMed ID: 10964104
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic profile of locally advanced and metastatic Schistosoma-related bladder cancer and response to chemotherapy.
Aly MS; Khaled HM; Emara M; Hussein TD
Cancer Genet; 2012 Apr; 205(4):156-62. PubMed ID: 22559976
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
Guo CC; Fine SW; Epstein JI
Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
[TBL] [Abstract][Full Text] [Related]
12. C-erb-2 gene amplification and chromosomal anomalies in bladder cancer: preliminary results.
Leonardo C; Merola R; Orlandi G; Leonardo F; Rondoni M; De Nunzio C
J Exp Clin Cancer Res; 2005 Dec; 24(4):633-8. PubMed ID: 16471327
[TBL] [Abstract][Full Text] [Related]
13. Alterations affecting the p53 control pathway in bilharzial-related bladder cancer.
Osman I; Scher HI; Zhang ZF; Pellicer I; Hamza R; Eissa S; Khaled H; Cordon-Cardo C
Clin Cancer Res; 1997 Apr; 3(4):531-6. PubMed ID: 9815716
[TBL] [Abstract][Full Text] [Related]
14. Uroplakin II gene is expressed in transitional cell carcinoma but not in bilharzial bladder squamous cell carcinoma: alternative pathways of bladder epithelial differentiation and tumor formation.
Wu RL; Osman I; Wu XR; Lu ML; Zhang ZF; Liang FX; Hamza R; Scher H; Cordon-Cardo C; Sun TT
Cancer Res; 1998 Mar; 58(6):1291-7. PubMed ID: 9515818
[TBL] [Abstract][Full Text] [Related]
15. Numerical aberrations of chromosomes 7, 9 and 17 in squamous cell and transitional cell cancer of the bladder: a comparative study performed by fluorescence in situ hybridization.
Pycha A; Mian C; Posch B; Haitel A; El-Baz M; Ghoneim MA; Marberger M
J Urol; 1998 Sep; 160(3 Pt 1):737-40. PubMed ID: 9720535
[TBL] [Abstract][Full Text] [Related]
16. [Detection of urothelial carcinoma of the urinary bladder by multicolor fluorescence in situ hybridization].
Zhang YG; Bi XG; Han YL; Cai Y; Xu X; Wu YP; Yang YL; Ma JH; Zhao P; Jia XM; Wang MR
Ai Zheng; 2007 Feb; 26(2):189-93. PubMed ID: 17298751
[TBL] [Abstract][Full Text] [Related]
17. Novel recurrent structural chromosomal aberrations in primary bladder cancer.
Panani AD; Ferti AD; Raptis SA; Roussos C
Anticancer Res; 2004; 24(5A):2967-74. PubMed ID: 15517903
[TBL] [Abstract][Full Text] [Related]
18. Numerical chromosome 1, 7, 9, and 11 aberrations in bladder cancer detected by in situ hybridization.
Hopman AH; Moesker O; Smeets AW; Pauwels RP; Vooijs GP; Ramaekers FC
Cancer Res; 1991 Jan; 51(2):644-51. PubMed ID: 1985781
[TBL] [Abstract][Full Text] [Related]
19. Detection of genetic alterations in primary bladder carcinoma with dual-color and multiplex fluorescence in situ hybridization.
Stamouli MI; Panani AD; Ferti AD; Petraki C; Oliver RT; Raptis SA; Young BD
Cancer Genet Cytogenet; 2004 Mar; 149(2):107-13. PubMed ID: 15036885
[TBL] [Abstract][Full Text] [Related]
20. Chromosome 8 numerical aberration and C-MYC copy number gain in bladder cancer are linked to stage and grade.
Mahdy E; Pan Y; Wang N; Malmström PU; Ekman P; Bergerheim U
Anticancer Res; 2001; 21(5):3167-73. PubMed ID: 11848469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
